High-Frequency MRI Monitoring Should Be Performed in Natalizumab-Treated MS Patients With Higher Risk of PML – Commentary
Multiple Sclerosis - United States
doi 10.1177/1352458516685170
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 1, 2017
Authors
Publisher
SAGE Publications